1743 related articles for article (PubMed ID: 11174732)
1. Late results of heart valve replacement with the Hancock II bioprosthesis.
David TE; Ivanov J; Armstrong S; Feindel CM; Cohen G
J Thorac Cardiovasc Surg; 2001 Feb; 121(2):268-77. PubMed ID: 11174732
[TBL] [Abstract][Full Text] [Related]
2. Clinical outcomes with the Hancock II bioprosthetic valve.
Masters RG; Haddad M; Pipe AL; Veinot JP; Mesana T
Ann Thorac Surg; 2004 Sep; 78(3):832-6. PubMed ID: 15337001
[TBL] [Abstract][Full Text] [Related]
3. Eighteen-year follow up after Hancock II bioprosthesis insertion.
Legarra JJ; Llorens R; Catalan M; Segura I; Trenor AM; de Buruaga JS; Rabago G; Sarralde A
J Heart Valve Dis; 1999 Jan; 8(1):16-24. PubMed ID: 10096477
[TBL] [Abstract][Full Text] [Related]
4. Fifteen-year results with the Hancock II valve: a multicenter experience.
Rizzoli G; Mirone S; Ius P; Polesel E; Bottio T; Salvador L; Zussa C; Gerosa G; Valfrè C
J Thorac Cardiovasc Surg; 2006 Sep; 132(3):602-9, 609.e1-4. PubMed ID: 16935116
[TBL] [Abstract][Full Text] [Related]
5. Early mechanical failures of the Hancock pericardial xenograft.
Bortolotti U; Milano A; Thiene G; Guerra F; Mazzucco A; Valente M; Talenti E; Gallucci V
J Thorac Cardiovasc Surg; 1987 Aug; 94(2):200-7. PubMed ID: 3613618
[TBL] [Abstract][Full Text] [Related]
6. Twenty-year experience with the St Jude Medical mechanical valve prosthesis.
Ikonomidis JS; Kratz JM; Crumbley AJ; Stroud MR; Bradley SM; Sade RM; Crawford FA
J Thorac Cardiovasc Surg; 2003 Dec; 126(6):2022-31. PubMed ID: 14688722
[TBL] [Abstract][Full Text] [Related]
7. Late outcomes for aortic valve replacement with the Carpentier-Edwards pericardial bioprosthesis: up to 17-year follow-up in 1,000 patients.
McClure RS; Narayanasamy N; Wiegerinck E; Lipsitz S; Maloney A; Byrne JG; Aranki SF; Couper GS; Cohn LH
Ann Thorac Surg; 2010 May; 89(5):1410-6. PubMed ID: 20417753
[TBL] [Abstract][Full Text] [Related]
8. Simultaneous aortic and mitral valve replacement: predictors of adverse outcome.
Kuwaki K; Tsukamoto M; Komatsu K; Morishita K; Sakata J; Abe T
J Heart Valve Dis; 2003 Mar; 12(2):169-76. PubMed ID: 12701788
[TBL] [Abstract][Full Text] [Related]
9. Aortic and mitral valve replacement with the Carpentier-Edwards pericardial bioprosthesis: 10-year results.
Murakami T; Eishi K; Nakano S; Kobayashi J; Sasako Y; Isobe F; Kosakai Y; Kito Y; Kawashima Y
J Heart Valve Dis; 1996 Jan; 5(1):45-9. PubMed ID: 8834725
[TBL] [Abstract][Full Text] [Related]
10. The Carpentier-Edwards standard porcine bioprosthesis. A first-generation tissue valve with excellent long-term clinical performance.
Jamieson WR; Allen P; Miyagishima RT; Gerein AN; Munro AI; Burr LH; Tyers GF
J Thorac Cardiovasc Surg; 1990 Mar; 99(3):543-61. PubMed ID: 2308373
[TBL] [Abstract][Full Text] [Related]
11. Twenty-year results of the Hancock II bioprosthesis.
Borger MA; Ivanov J; Armstrong S; Christie-Hrybinsky D; Feindel CM; David TE
J Heart Valve Dis; 2006 Jan; 15(1):49-55; discussion 55-6. PubMed ID: 16480012
[TBL] [Abstract][Full Text] [Related]
12. Clinical outcomes with the epicholorohydrin-modified porcine aortic heart valve: a 15-year follow-up.
Wei X; Yi W; Chen W; Ma X; Lau WB; Wang H; Yi D
Ann Thorac Surg; 2010 May; 89(5):1417-24. PubMed ID: 20417754
[TBL] [Abstract][Full Text] [Related]
13. The homograft aortic valve: a 29-year, 99.3% follow up of 1,022 valve replacements.
O'Brien MF; Harrocks S; Stafford EG; Gardner MA; Pohlner PG; Tesar PJ; Stephens F
J Heart Valve Dis; 2001 May; 10(3):334-44; discussion 335. PubMed ID: 11380096
[TBL] [Abstract][Full Text] [Related]
14. Valve-related complications with the Hancock I porcine bioprosthesis. A twelve- to fourteen-year follow-up study.
Bernal JM; Rabasa JM; Cagigas JC; Echevarria JR; Carrion MF; Revuelta JM
J Thorac Cardiovasc Surg; 1991 May; 101(5):871-80. PubMed ID: 2023444
[TBL] [Abstract][Full Text] [Related]
15. Experience with low-dose aspirin as thromboprophylaxis for the Tissuemed porcine aortic bioprosthesis: a survey of five years' experience.
Goldsmith I; Lip GY; Mukundan S; Rosin MD
J Heart Valve Dis; 1998 Sep; 7(5):574-9. PubMed ID: 9793859
[TBL] [Abstract][Full Text] [Related]
16. Late incidence and determinants of reoperation in patients with prosthetic heart valves.
Ruel M; Kulik A; Rubens FD; Bédard P; Masters RG; Pipe AL; Mesana TG
Eur J Cardiothorac Surg; 2004 Mar; 25(3):364-70. PubMed ID: 15019662
[TBL] [Abstract][Full Text] [Related]
17. Morphologic findings in explanted Hancock II porcine bioprostheses.
Butany J; Yu W; Silver MD; David TE
J Heart Valve Dis; 1999 Jan; 8(1):4-15. PubMed ID: 10096476
[TBL] [Abstract][Full Text] [Related]
18. Aortic valve replacement with the Hancock standard, Björk-Shiley, and Lillehei-Kaster prostheses. A comparison based on follow-up from 1 to 15 years.
Milano AD; Bortolotti U; Mazzucco A; Guerra F; Magni A; Gallucci V
J Thorac Cardiovasc Surg; 1989 Jul; 98(1):37-47. PubMed ID: 2739424
[TBL] [Abstract][Full Text] [Related]
19. Long-term results of aortic valve replacement with the St. Jude Toronto stentless porcine valve.
Desai ND; Merin O; Cohen GN; Herman J; Mobilos S; Sever JY; Fremes SE; Goldman BS; Christakis GT
Ann Thorac Surg; 2004 Dec; 78(6):2076-83; discussion 2076-83. PubMed ID: 15561040
[TBL] [Abstract][Full Text] [Related]
20. Aortic and mitral valve replacement in children: is there any role for biologic and bioprosthetic substitutes?
Alsoufi B; Manlhiot C; McCrindle BW; Canver CC; Sallehuddin A; Al-Oufi S; Joufan M; Al-Halees Z
Eur J Cardiothorac Surg; 2009 Jul; 36(1):84-90; discussion 90. PubMed ID: 19369085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
